Related Experiment Video
Updated: Apr 23, 2026

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
Published on: April 29, 2020
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis
Katarzyna Dzitko1, Agata Paneth2, Tomasz Plech3
1Department of Immunoparasitology, University of Lodz, Lodz, Poland dzika@biol.uni.lodz.pl.
Abstract:
This article reports anti-Toxoplasma gondii activity of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione. The compound displayed significant and reproducible antiparasitic effects at nontoxic concentrations for the host cells, with an experimentally determined 50% inhibitory concentration (IC50) at least 30 times better than that of the known chemotherapeutic agent sulfadiazine. Purine nucleoside phosphorylase was defined as the probable target for anti-Toxoplasma activity of the tested compound. These results provide the foundation for future work to develop a new class of medicines to better treat toxoplasmosis.
Related Concept Videos
Anthelminthic Agents
Teratogenicity
Antifungal Agents
Aryldiazonium Salts to Azo Dyes: Diazo Coupling

